| Ella M Wright, NP | |
|
960 Dantzler St, Orangeburg, SC 29115-4322 | |
| (803) 937-5823 | |
| (803) 747-7297 |
| Full Name | Ella M Wright |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 960 Dantzler St, Orangeburg, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891170007 | NPI | - | NPPES |
| PENDING | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 19636 (South Carolina) | Primary |
| Entity Name | Medical Center Of Santee Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114935475 PECOS PAC ID: 4082611041 Enrollment ID: O20080319000339 |
News Archive
Scientists at the Helmholtz Zentrum München, the Ludwig-Maximilians University of Munich (LMU) and the Technische Universität München (TUM) have moved an important step closer to understanding molecular mechanisms of autoimmune diseases.
In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo (USP) have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors.
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) - a rare kidney disease which can lead to kidney failure.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has entered into a Patent License Agreement with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services
› Verified 8 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191209002986 |
News Archive
Scientists at the Helmholtz Zentrum München, the Ludwig-Maximilians University of Munich (LMU) and the Technische Universität München (TUM) have moved an important step closer to understanding molecular mechanisms of autoimmune diseases.
In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo (USP) have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors.
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) - a rare kidney disease which can lead to kidney failure.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has entered into a Patent License Agreement with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ella M Wright, NP 960 Dantzler St, Orangeburg, SC 29115-4322 Ph: (803) 937-5823 | Ella M Wright, NP 960 Dantzler St, Orangeburg, SC 29115-4322 Ph: (803) 937-5823 |
News Archive
Scientists at the Helmholtz Zentrum München, the Ludwig-Maximilians University of Munich (LMU) and the Technische Universität München (TUM) have moved an important step closer to understanding molecular mechanisms of autoimmune diseases.
In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo (USP) have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors.
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) - a rare kidney disease which can lead to kidney failure.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has entered into a Patent License Agreement with the National Institutes of Health, an agency of the United States Public Health Service within the Department of Health and Human Services
› Verified 8 days ago
Catherine Simmons, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3310 Magnolia Centers Inc, Orangeburg, SC 29115 Phone: 843-701-6387 | |
Shannon W Easterlin, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 940 Holly St, Orangeburg, SC 29115 Phone: 803-536-2725 Fax: 803-534-3118 | |
Monica Monique Johnson, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3000 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-395-2200 | |
Constance Gainey Bailey, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3000 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-395-2200 | |
Vincent Bernard Johnson, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900 | |
Ms. Erica Thompson, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1773 Village Park Drive, Orangeburg, SC 29118 Phone: 803-535-3600 | |
Jennifer Haynes, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 970 Holly St, Orangeburg, SC 29115 Phone: 803-531-2722 Fax: 803-531-2743 |